25 Stocks Moving In Friday's Mid-Day Session

Gainers

• Helbiz, Inc. HLBZ shares jumped 92.7% to $17.35 after the company announced its media unit has entered into an agreement with FOX Networks to broadcast the Italian Serie B championship across the USA and the Caribbean.
• Corvus Pharmaceuticals, Inc. CRVS climbed 83.9% to $4.1550.
• Innate Pharma S.A. IPHA shares climbed 56.2% to $8.98 as its partner AstraZeneca Plc AZN presented results from the COAST Phase 2 trial during the European Society for Medical Oncology (ESMO21) Congress 2021. SVB Leerink maintained Innate Pharma with an Outperform and raised the price target from $7 to $9.
• SmileDirectClub, Inc. SDC rose 17.8% to $7.07 as traders on social media circulated the stock, highlighting high short interest.
• Nexters Inc. GDEV gained 17.5% to $11.40. Nexters is expected to report Q2 results on September 22.
• Doma Holdings Inc. DOMA gained 11.3% to $8.72. Oppenheimer initiated coverage on Doma Holdings with an Outperform rating and announced a price target of $11.
• Lucid Group, Inc. LCID rose 10.1% to $7.07. Lucid Group gained over 6% on Thursday after the company's Lucid Air Dream Edition Range received an official EPA rating of 520 miles of range.
• ForgeRock, Inc. FORG jumped 9.5% to $39.98. The company recently priced its IPO at $25 per share.
• Berkshire Grey, Inc. BGRY gained 9% to $7.30.
• I-Mab IMAB shares surged 8.6% to $74.02.
• CuriosityStream Inc. CURI surged 8.2% to $11.98. JP Morgan initiated coverage on CuriosityStream with an Overweight rating and announced a price target of $15.
• Surface Oncology, Inc. SURF rose 7.7% to $6.47.
• BeiGene, Ltd. BGNE rose 7.3% to $413.19. BeiGene CEO John Oyler reported the sale of 411,838 shares in a Form 4 filing on Thursday.
• Thermo Fisher Scientific Inc. TMO gained 5.3% to $589.88 after the company issued FY22 EPS and sales guidance above analyst estimates.
• Invesco Ltd. IVZ rose 5% to $26.14. Invesco is in merger talks with State Street's asset management business, according to the Wall Street Journal.

Check out these big penny stock gainers and losers

Losers

• Protagonist Therapeutics, Inc. PTGX shares dipped 61.1% to $17.96 after the company reported the FDA placed a clinical hold on rusfertide development program.
• TCR2 Therapeutics Inc. TCRR fell 31.3% to $10.80 after the company announced interim results from an ongoing Phase 1/2 trial of gavo-cel for the treatment of refractory mesothelin-expressing solid tumors.
• IronNet Cybersecurity, Inc. IRNT fell 20.1% to $33.08. IronNet shares climbed over 28% on Thursday amid increased retail investor interest in the stock on social media.
• Vera Therapeutics, Inc. VERA dropped 18.7% to $18.27 after tumbling 26% on Thursday.
• Offerpad Solutions Inc OPAD shares fell 16% to $16.79. Offerpad Solutions shares jumped over 58% on Thursday amid increased retail investor interest in the stock on social media.
• AEye, Inc. LIDR dropped 12.7% to $8.59.
• Generation Bio Co. GBIO fell 11.8% to $23.95.
• Syros Pharmaceuticals, Inc. SYRS dropped 10.5% to $4.8750. Syros recently said that the first patient was dosed in SELECT-AML-1 trial of tamibarotene in combination with venetoclax and azacitidine in newly diagnosed unfit AML.
• EZFill Holdings Inc. EZFL shares fell 10.3% to $4.6652 after jumping around 15% on Thursday. The company recently priced its IPO at 4 per share.
• Auddia Inc. AUUD dropped 6.7% to $2.93 after Maxim Group initiated coverage on the stock with a Buy rating and announced a $9 price target.